An accomplished scientist with deep expertise in wound care and medical device microbiology, underpinned by a robust academic foundation in analytical chemistry, microbiology, and nanotechnology. Currently working in a GMP-regulated lab, they specialise in evaluating the antimicrobial performance of wound care medical devices, including bioburden and endotoxin testing, and leading microbiological analyses that directly inform R&D and product release.
With a PhD focused on nanoparticle-encapsulated antibiotics for treating clinical wound pathogens, they bring advanced experience in formulating novel therapeutic systems aimed at overcoming antimicrobial resistance. Their research has led to 11 peer-reviewed publications and multiple international conference presentations, showcasing strong scientific communication and analytical skills.
In addition to laboratory expertise—including HPLC, PCR, FTIR, rheology, and antimicrobial susceptibility testing—they have proven project leadership and mentoring experience, having supervised both academic and industry-linked research projects. Their work bridges the academic and commercial worlds, having collaborated with multidisciplinary teams and industrial partners.
With a track record of innovation, regulatory compliance (GMP/GLP), and scientific rigour, this candidate is exceptionally well-suited for R&D roles in medical device companies, particularly within wound care, infection control, and advanced therapeutic formulation.